Hiroaki Ishibashi

749 citations
31 papers · 588 indexed · h-index 13
Topics
Angiogenesis and VEGF in Cancer (6 papers)Cancer, Hypoxia, and Metabolism (5 papers)Fibroblast Growth Factor Research (4 papers)
Partner nations
JapanGermanyCzechia

In The Last Decade

Hiroaki Ishibashi

29 papers receiving 566 citations

Peers

Hiroaki Ishibashi
Comparison fields: 5 of 94
  • Molecular Biology 239
  • Surgery 113
  • Cancer Research 97
  • Oncology 84
  • Oral Surgery 73
Replace Yunong Wu with:
Yunong Wu China
Yoko Miwa Japan
Satoshi Rokutanda Japan
Naoya Izumi Japan
Norifumi Moritani Japan
J. Haubrich Germany
Mizuo Sugimoto Japan
Tianqian Hui China
Aruna Khare United States
Yuji Taya Japan
Hiroaki Ishibashi relative to Yunong Wu China Yunong Wu's profile →
Citations per field
00.5×1.5×
Yunong Wu · 1×
Citations per year

Countries citing papers authored by Hiroaki Ishibashi

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Ishibashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Ishibashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Ishibashi more than expected).

Fields of papers citing papers by Hiroaki Ishibashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Ishibashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Ishibashi. The network helps show where Hiroaki Ishibashi may publish in the future.

Co-authorship network of co-authors of Hiroaki Ishibashi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Ishibashi. A scholar is included among the top collaborators of Hiroaki Ishibashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Ishibashi. Hiroaki Ishibashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 17
2 26
3 6
4 18
5 1
6 30
7 3
8 1
9 8
10 2
11 40
12
1
13 27
14
0
15 44
16
Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor beta1, and tissue factor and also cell growth and invasion activities.
83
17 26
18 12
19 66
20 3

About Hiroaki Ishibashi

Hiroaki Ishibashi is a scholar working on Otorhinolaryngology, Oral Surgery and Complementary and Manual Therapy, having authored 31 papers that have together received 588 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Fibroblast Growth Factor Research (4 papers). The work is most often cited by research in Complementary and Manual Therapy (66 citations), Orthodontics (58 citations) and Oral Surgery (73 citations). Hiroaki Ishibashi has collaborated with scholars based in Japan, Germany and Czechia. Frequent co-authors include Kanemitsu Shirasuna, Katsuo Sueishi, Mitsuho Onimaru, Kazunori Nakagawa, Masuichiro OKA, Yasuharu TAKENOSHITA, Yoshikazu Yonemitsu, Joji Sekine, Yoshiki Nariai and Yutaka Nakashima. Their work appears in journals such as Circulation Research, Scientific Reports and American Journal Of Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026